Faculty
Martin A. Cohn, MD, FACP
Joseph Ojile, MD, FCCP
Gary Richardson, MD
Martin A. Cohn, MD
Director, Sleep Disorders Center of Southwest Florida
Volunteer Associate Professor of Medicine, University of Miami
Naples, FL
Dr. Martin Cohn received his MD from University of Miami Medical School in 1970 and is Board Certified in Internal Medicine (University of Miami, 1973), Pulmonary Disease subspecialty (Mt. Sinai Medical Center, Miami Beach, 1977) and Sleep Disorders (since 1978). Dr. Cohn was Associate Professor of Medicine, University of Miami at Mt. Sinai, training fellows in both Pulmonary Disease and Sleep Disorders until moving to Naples in 1989 to become the Medical Director of the Nationally Accredited Sleep Disorders Center of SW Florida. He remains a Volunteer Associate Professor of Medicine for the University of Miami and practices sleep medicine full-time as well as conducting clinical research trials.
Joseph Ojile, MD
Assistant Clinical Professor, Internal Medicine
School of Allied Health, Saint Louis University
Corporate Medical Director of Inpatient Management, Inc.
St. Louis, MO
Dr. Joseph Ojile is an Assistant Clinical Professor of Medicine/Pulmonary Disease at St. Louis University of Medicine. Dr. Ojile is in private practice and Board Certified in internal medicine, pulmonary disease and sleep medicine. He is also Managing Director of the Clayton Sleep Institute and St. Anthony’s Sleep Disorder Centers. In addition, Dr. Ojile serves as President of Alliance Inpatient Management and Corporate Medical Director of Inpatient Management Inc.
Dr. Ojile lectures nationally on issues related to sleep and pulmonary disease.
Gary Richardson, MD
Senior Research Scientist
Sleep Research and Disorders Center
Henry Ford Hospital
Detroit, MI
Gary Richardson, M.D. is Senior Research Scientist in the Sleep Research Laboratory, Henry Ford Hospital, and Assistant Professor of Psychiatry at Case Western Reserve University School of Medicine. Dr. Richardson received undergraduate and medical training at Stanford University, where he began research on basic circadian rhythmicity and the control of sleep and wakefulness. He subsequently completed an internal medicine residency at Brigham and Women’s Hospital in Boston, and endocrinology and neurology fellowships at Massachusetts General Hospital. Dr. Richardson was a pioneer among sleep disorders specialists in focusing on the clinical management of circadian rhythm sleep disorders, including the provision of specialized care to shift workers with difficulty adapting to shift schedules. Dr. Richardson’s current research focus is on central mechanisms involved in the pathogenesis of sleep disorders.
As a sponsor accredited by the ACCME, InforMED, must ensure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational activities. All faculty participating in a sponsored activity are expected to disclose to the activity audience any significant financial interest or other relationship (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. (Significant financial interest or other relationship can include such things as grants or research support, employee, consultant, major stockholder, member of speakers bureaus, etc.) The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making a presentation, but rather to provide listeners with information on which they can make their own judgments. It remains for the audience to determine whether the speakers’ interests or relationships may influence the presentation with regard to exposition or conclusion.
Martin Cohn, MD, FACP receives honorarium from King Pharmaceuticals, Inc. ,for his participation in this program, Dr. Cohn also disclosed that he has performed clinical trials and has worked as a speaker and/or consultant for King Pharmaceuticals, Inc., Sanofi-Aventis, and Sepracor, Inc.
Joseph Ojile, MD receives honorarium from King Pharmaceuticals, Inc., Sanofi-Aventis, GlaxoSmithKline, Sepracor, Inc and Pfizer, Inc. He has participated on the speakers bureaus for King Pharmaceuticals, Inc, Sanofi-Aventis, GlaxoSmithKline, Sepracor, Inc. and Pfizer, Inc.
Gary Richardson, MD receives honorarium from King Pharmaceuticals, Inc., Sanofi-Aventis, Sepracor, Inc., Takeda Pharmaceuticals, Pfizer Inc. and Cephalon, Inc. Dr. Richardson has participated as a consultant for King Pharmaceuticals, Inc., Sanofi-Aventis, Takeda Pharmaceuticals, and Cephalon Inc. He has also received grants/research support from Vanda Pharmaceuticals, Takeda Pharmaceuticals and Pfizer Inc.
